Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1349


When Cognitive Decline and Depression Coexist in the Elderly: CSF Biomarkers Analysis Can Differentiate Alzheimer's Disease from Late-Life Depression.

Liguori C, Pierantozzi M, Chiaravalloti A, Sancesario GM, Mercuri NB, Franchini F, Schillaci O, Sancesario G.

Front Aging Neurosci. 2018 Feb 23;10:38. doi: 10.3389/fnagi.2018.00038. eCollection 2018.


Atypical Localization and Dissociation between Glucose Uptake and Amyloid Deposition in Cognitively Normal APOE*E4 Homozygotic Elders Compared with Patients with Late-Onset Alzheimer's Disease.

Pardo JV, Lee JT; Alzheimer’s Disease Neuroimaging Initiative*.

eNeuro. 2018 Feb 28;5(1). pii: ENEURO.0396-17.2018. doi: 10.1523/ENEURO.0396-17.2018. eCollection 2018 Jan-Feb.


The Spanish version of Face-Name Associative Memory Exam (S-FNAME) performance is related to amyloid burden in Subjective Cognitive Decline.

Sanabria A, Alegret M, Rodriguez-Gomez O, Valero S, Sotolongo-Grau O, Monté-Rubio G, Abdelnour C, Espinosa A, Ortega G, Perez-Cordon A, Gailhajanet A, Hernandez I, Rosende-Roca M, Vargas L, Mauleon A, Sanchez D, Martin E, Rentz DM, Lomeña F, Ruiz A, Tarraga L, Boada M; FACEHBI study group.

Sci Rep. 2018 Feb 28;8(1):3828. doi: 10.1038/s41598-018-21644-y.


Thiamine diphosphate reduction strongly correlates with brain glucose hypometabolism in Alzheimer's disease, whereas amyloid deposition does not.

Sang S, Pan X, Chen Z, Zeng F, Pan S, Liu H, Jin L, Fei G, Wang C, Ren S, Jiao F, Bao W, Zhou W, Guan Y, Zhang Y, Shi H, Wang Y, Yu X, Wang Y, Zhong C.

Alzheimers Res Ther. 2018 Mar 1;10(1):26. doi: 10.1186/s13195-018-0354-2.


Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).

Jessen F, Spottke A, Boecker H, Brosseron F, Buerger K, Catak C, Fliessbach K, Franke C, Fuentes M, Heneka MT, Janowitz D, Kilimann I, Laske C, Menne F, Nestor P, Peters O, Priller J, Pross V, Ramirez A, Schneider A, Speck O, Spruth EJ, Teipel S, Vukovich R, Westerteicher C, Wiltfang J, Wolfsgruber S, Wagner M, Düzel E.

Alzheimers Res Ther. 2018 Feb 7;10(1):15. doi: 10.1186/s13195-017-0314-2.


Comparison of Standardized Uptake Value Ratio Calculations in Amyloid Positron Emission Tomography Brain Imaging.

Knešaurek K, Warnock G, Kostakoglu L, Burger C; for Alzheimer's Disease Neouroimaging Initiative*.

World J Nucl Med. 2018 Jan-Mar;17(1):21-26. doi: 10.4103/wjnm.WJNM_5_17.


Alteration of Copper Fluxes in Brain Aging: A Longitudinal Study in Rodent Using 64CuCl2-PET/CT.

Peng F, Xie F, Muzik O.

Aging Dis. 2018 Feb 1;9(1):109-118. doi: 10.14336/AD.2017.1025. eCollection 2018 Feb.


FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort.

Caminiti SP, Ballarini T, Sala A, Cerami C, Presotto L, Santangelo R, Fallanca F, Vanoli EG, Gianolli L, Iannaccone S, Magnani G, Perani D; BIOMARKAPD Project.

Neuroimage Clin. 2018 Jan 28;18:167-177. doi: 10.1016/j.nicl.2018.01.019. eCollection 2018.


Tau Positron Emission Tomography Imaging in Degenerative Parkinsonisms.

Lyoo CH, Cho H, Choi JY, Ryu YH, Lee MS.

J Mov Disord. 2018 Jan;11(1):1-12. doi: 10.14802/jmd.17071. Epub 2018 Jan 23. Review.


In Vivo Tau Imaging for a Diagnostic Platform of Tauopathy Using the rTg4510 Mouse Line.

Sahara N, Shimojo M, Ono M, Takuwa H, Febo M, Higuchi M, Suhara T.

Front Neurol. 2017 Dec 7;8:663. doi: 10.3389/fneur.2017.00663. eCollection 2017. Review.


Classification of Alzheimer's Disease, Mild Cognitive Impairment, and Cognitively Unimpaired Individuals Using Multi-feature Kernel Discriminant Dictionary Learning.

Li Q, Wu X, Xu L, Chen K, Yao L; Alzheimer's Disease Neuroimaging Initiative.

Front Comput Neurosci. 2018 Jan 9;11:117. doi: 10.3389/fncom.2017.00117. eCollection 2017.


A novel individual-level morphological brain networks constructing method and its evaluation in PET and MR images.

Jiang J, Zhou H, Duan H, Liu X, Zuo C, Huang Z, Yu Z, Yan Z; Alzheimer's Disease Neuroimaging Initiative.

Heliyon. 2017 Dec 28;3(12):e00475. doi: 10.1016/j.heliyon.2017.e00475. eCollection 2017 Dec.


Assessment of change in glucose metabolism in white matter of amyloid-positive patients with Alzheimer disease using F-18 FDG PET.

Jeong YJ, Yoon HJ, Kang DY.

Medicine (Baltimore). 2017 Dec;96(48):e9042. doi: 10.1097/MD.0000000000009042.


Cross-sectional variations of white and grey matter in older hypertensive patients with subjective memory complaints.

Chetouani A, Chawki MB, Hossu G, Kearney-Schwartz A, Chauveau-Beuret F, Bracard S, Roch V, Lebon V, Marie PY, Benetos A, Joly L, Verger A.

Neuroimage Clin. 2017 Dec 18;17:804-810. doi: 10.1016/j.nicl.2017.12.024. eCollection 2018.


A new data analysis approach for measuring longitudinal changes of metabolism in cognitively normal elderly adults.

Shokouhi S, Riddle WR, Kang H.

Clin Interv Aging. 2017 Dec 14;12:2123-2130. doi: 10.2147/CIA.S150859. eCollection 2017.


Diagnosing Corticobasal Syndrome Based on the Presence of Visual Hallucinations and Imaging with Amyloid Positron Emission Tomography.

Nishida H, Hayashi Y, Harada N, Sakurai T, Wakida K.

Intern Med. 2018 Feb 15;57(4):605-611. doi: 10.2169/internalmedicine.8534-16. Epub 2017 Dec 21.


Optimizing the preclinical Alzheimer's cognitive composite with semantic processing: The PACC5.

Papp KV, Rentz DM, Orlovsky I, Sperling RA, Mormino EC.

Alzheimers Dement (N Y). 2017 Nov 10;3(4):668-677. doi: 10.1016/j.trci.2017.10.004. eCollection 2017 Nov.


Application of Haralick texture features in brain [<sup>18</sup>F]-florbetapir positron emission tomography without reference region normalization.

Campbell DL, Kang H, Shokouhi S.

Clin Interv Aging. 2017 Dec 7;12:2077-2086. doi: 10.2147/CIA.S143307. eCollection 2017.


Deep Learning based Classification of FDG-PET Data for Alzheimers Disease Categories.

Singh S, Srivastava A, Mi L, Caselli RJ, Chen K, Goradia D, Reiman EM, Wang Y.

Proc SPIE Int Soc Opt Eng. 2017 Oct;10572. pii: 105720J. doi: 10.1117/12.2294537. Epub 2017 Nov 17.


Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer's disease.

Wang MJ, Yi S, Han JY, Park SY, Jang JW, Chun IK, Kim SE, Lee BS, Kim GJ, Yu JS, Lim K, Kang SM, Park YH, Youn YC, An SSA, Kim S.

Alzheimers Res Ther. 2017 Dec 15;9(1):98. doi: 10.1186/s13195-017-0324-0.

Supplemental Content

Loading ...
Support Center